Cargando…

SOCS3 Genetic Polymorphism Is Associated With Clinical Features and Prognosis of Hepatocellular Carcinoma Patients Receiving Hepatectomy

Previous studies showed that suppressor of cytokine signaling 3 (SOCS3) protein is associated with incidence and progression of hepatocellular carcinoma (HCC); however, the association between the genetic polymorphism of SOCS3 gene and HCC remains unknown. A total of 254 HCC patients and 354 healthy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Bei-ge, Yang, Yuan, Liu, Hui, Gu, Fang-ming, Yang, Yun, Zhao, Lin-Hao, Yuan, Sheng-xian, Wang, Ruo-yu, Zhang, Jin, Zhou, Wei-ping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2015
Materias:	5700
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4616756/ https://www.ncbi.nlm.nih.gov/pubmed/26447993 http://dx.doi.org/10.1097/MD.0000000000001344

Ejemplares similares

Risk factors and long-term outcome for postoperative intra-abdominal infection after hepatectomy for hepatocellular carcinoma
por: Tang, Haowen, et al.
Publicado: (2017)

Combined low miRNA-29s is an independent risk factor in predicting prognosis of patients with hepatocellular carcinoma after hepatectomy: A Chinese population-based study
por: Zhang, Zhen, et al.
Publicado: (2017)

Impact of tenofovir antiviral treatment on survival of chronic hepatitis B related hepatocellular carcinoma after hepatectomy in Chinese individuals from Qingdao municipality
por: Ge, Zhong, et al.
Publicado: (2020)

Tumor PHD2 Expression Is Correlated With Clinical Features and Prognosis of Patients With HCC Receiving Liver Resection
por: Zhen, Li, et al.
Publicado: (2014)

Association between SOCS3 hypermethylation and HBV-related hepatocellular carcinoma and effect of sex and age: A meta-analysis
por: Zheng, Hairu, et al.
Publicado: (2021)

Screening of significant biomarkers with poor prognosis in hepatocellular carcinoma via bioinformatics analysis
por: Sun, Quanquan, et al.
Publicado: (2020)

Higher neutrophil-lymphocyte ratio is associated with better prognosis of hepatocellular carcinoma
por: Li, Sheng-chao, et al.
Publicado: (2020)

Clinical value of circulating tumor cells for the diagnosis and prognosis of hepatocellular carcinoma (HCC): A systematic review and meta-analysis
por: Cui, Kai, et al.
Publicado: (2020)

Serum SALL4 as a predictive biomarker for the prognosis of patients with hepatocellular carcinoma who underwent nonsurgical treatment
por: Chen, Zhixian, et al.
Publicado: (2022)

Association of TNIP1 polymorphisms with hepatocellular carcinoma in a Northwest Chinese Han population
por: Shi, Yuting, et al.
Publicado: (2021)

Recurrence of Hepatocellular Carcinoma With Epithelial–Mesenchymal Transition After Spontaneous Regression: A Case Report
por: Yang, Shi-zhong, et al.
Publicado: (2015)

Clinicopathological features and prognosis of coexistence of gastric gastrointestinal stromal tumor and gastric cancer
por: Liu, Zhen, et al.
Publicado: (2016)

Overexpression of microRNA let-7 correlates with disease progression and poor prognosis in hepatocellular carcinoma
por: Shi, Wenxia, et al.
Publicado: (2017)

A pan-cancer analysis of the MAPK family gene and their association with prognosis, tumor microenvironment, and therapeutic targets
por: Qin, Yuan-Yuan, et al.
Publicado: (2023)

The effect of pretreatment BMI on the prognosis and serum immune cells in advanced LSCC patients who received ICI therapy
por: Wang, Fei, et al.
Publicado: (2021)

Impact of intraoperative allogenic and autologous transfusion on immune function and prognosis in patients with hepatocellular carcinoma
por: Gong, Youwei, et al.
Publicado: (2020)

Identification of cancer-associated fibroblasts signature for predicting the prognosis and immunotherapy response in hepatocellular carcinoma
por: Ye, Jianzhong, et al.
Publicado: (2023)

Integrated analysis identifies a long non-coding RNAs-messenger RNAs signature for prediction of prognosis in hepatitis B virus-hepatocellular carcinoma patients
por: Bai, Zhenzi, et al.
Publicado: (2020)

Correlation of microRNA-367 in the clinicopathologic features and prognosis of breast cancer patients
por: Liu, Binghui, et al.
Publicado: (2021)

Impact of regulatory T cells on the prognosis of hepatocellular carcinoma: A protocol for systematic review and meta analysis
por: Shi, Xinhui, et al.
Publicado: (2021)

The clinical features, treatment, and prognosis of primary mediastinal malignant melanoma: A case report
por: Li, ZiHai, et al.
Publicado: (2017)

Clinical features and prognosis of duplex primary malignant neoplasms involving chronic myeloid leukemia
por: Liu, Chunshui, et al.
Publicado: (2020)

Ferroptosis-related long non-coding RNA signature predicts the prognosis of hepatocellular carcinoma: A Review
por: Bu, Fan, et al.
Publicado: (2022)

The clinicopathological features and prognostic factors of gastric squamous cell carcinoma
por: Dong, Caixia, et al.
Publicado: (2016)

Clinical features of 18 perivascular epithelioid cell tumor cases
por: Jia, Rongfei, et al.
Publicado: (2020)

Comparison of ultrasound-guided radiofrequency ablation and hepatectomy for colorectal liver metastasis: A protocol for systematic review and meta-analysis
por: Wu, Lianming, et al.
Publicado: (2023)

Predictive Value of Ercc1 and Xpd Polymorphisms for Clinical Outcomes of Patients Receiving Neoadjuvant Therapy: A Prisma-Compliant Meta-Analysis
por: Qixing, Mao, et al.
Publicado: (2015)

Tumor necrosis factor alpha-238G/A polymorphism and risk of breast cancer: An update by meta-analysis
por: Zhang, Qing, et al.
Publicado: (2017)

Statin-Based Palliative Therapy for Hepatocellular Carcinoma
por: Shao, Joni Yu-Hsuan, et al.
Publicado: (2015)

Increased expression of insulin-like growth factor-1 receptor predicts poor prognosis in patients with hepatocellular carcinoma
por: Zhang, Zhiquan, et al.
Publicado: (2019)

Increased expression of long non-coding RNA CCAT2 predicts poorer prognosis in patients with hepatocellular carcinoma
por: Fu, Changbo, et al.
Publicado: (2019)

Identification of an 11-lncRNA signature with high performance for predicting the prognosis of hepatocellular carcinoma using bioinformatics analysis
por: Wang, Anmei, et al.
Publicado: (2021)

Nomogram to predict the prognosis of patients with AFP-negative hepatocellular carcinoma undergoing chemotherapy: A SEER based study
por: Wang, Lei, et al.
Publicado: (2023)

Comprehensive analysis of diverse programmed cell death patterns in the prognosis, tumor microenvironment and drug sensitivity in hepatocellular carcinoma
por: Yu, Youlin, et al.
Publicado: (2023)

Promising significance of the association of miR-204-5p expression with clinicopathological features of hepatocellular carcinoma
por: Luo, Yi-Huan, et al.
Publicado: (2017)

Co-expression of KIAA1199 and hypoxia-inducible factor 1α is a biomarker for an unfavorable prognosis in hepatocellular carcinoma
por: Wang, Dan, et al.
Publicado: (2020)

Short-term prognosis for hepatocellular carcinoma patients with lung metastasis: A retrospective cohort study based on the SEER database
por: Chen, Shicheng, et al.
Publicado: (2022)

Pneumonitis in cancer patients receiving anti-PD-1 and radiotherapies: Three case reports
por: Lu, Chieh-Sheng, et al.
Publicado: (2017)

Clinicopathological analysis of 67 cases of esophageal neuroendocrine carcinoma and the effect of postoperative adjuvant therapy on prognosis
por: Liu, Shenxiang, et al.
Publicado: (2021)

Responses to crizotinib and cabozantinib in patient with lung adenocarcinoma harboring mesenchymal-epithelial transition factor exon 14 skipping mutation: A case report
por: Qin, Ruo-Yan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vglnkjefo73fu04d0djjigbgcb